This inventor holds 3 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1988-1998.
Company Filing History:
Years Active: 1988-1998
Title: Innovations by Deborah A. Paul
Introduction
Deborah A. Paul is a notable inventor based in Gurnee, IL (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies for the detection and treatment of Hepatitis E Virus (HEV). With a total of 3 patents to her name, her work has had a meaningful impact on medical research and diagnostics.
Latest Patents
Deborah's latest patents include innovative methods and products related to HEV. One of her patents, titled "HEV orf-2 monoclonal antibodies and methods for using same," describes monoclonal antibodies that specifically bind to the HEV orf-2 antigen. This patent also includes hybridoma cell lines that secrete these antibodies, along with methods for their application and assay kits containing these antibodies. Another significant patent is "Mouse monoclonal antibodies to Hepatitis E virus and methods for using," which focuses on antibodies that bind to the HEV orf-3 antigen, providing similar hybridoma cell lines and methods for their use.
Career Highlights
Deborah A. Paul is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to collaborate with other experts in the field, enhancing the development of innovative solutions for viral infections.
Collaborations
One of her notable collaborators is Mark F. Knigge, with whom she has worked closely on various projects related to her patents.
Conclusion
Deborah A. Paul is a distinguished inventor whose work in monoclonal antibodies has advanced the understanding and treatment of Hepatitis E Virus. Her contributions continue to influence the field of biotechnology and medical research.